I Leader della Finanza

Ultime notizieSocietÓMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaCalendarioSettori 
HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza
Riassunto 
Lindsay Allan Rosenwald is an entrepreneur and businessperson who founded 7 companies, among them: TG Therapeutics, Inc., Cougar Biotechnology, Inc. and Keryx Biopharmaceuticals, Inc. and who has been at the helm of 13 different companies. Presently, he occupies the position of Chairman, President & Chief Executive Officer of Fortress Biotech, Inc., Executive Chairman at Cyprium Therapeutics, Inc. (which he founded in 2017) and President & Chief Executive Officer of Cellvation, Inc. (both are subsidiaries of Fortress Biotech, Inc.), Executive Chairman for Avenue Therapeutics, Inc., Executive Chairman of Helocyte, Inc., Executive Chairman at Journey Medical Corp. and Partner at Opus Point Partners Management LLC (which he founded in 2009). Lindsay Allan Rosenwald is also on the board of Checkpoint Therapeutics, Inc. (former President, Chief Executive Officer & Director), Mustang Bio, Inc. and Caelum Biosciences, Inc.

Dr. Rosenwald previously was Chairman & Chief Executive Officer for Paramount BioCapital, Inc. Chairman & Chief Executive Officer at Paramount BioCapital Asset Management, Inc. and Chairman & Chief Executive Officer at Paramount BioSciences LLC (both are subsidiaries of Paramount BioCapital, Inc.), Co-Chairman & Chief Executive Officer at Origo Acquisition Corp., Managing Director at D.H. Blair & Co., Inc., Chairman at Paramount Acquisition Corp., Securities Analyst at Ladenburg Thalmann & Co., Inc., Director at Keryx Biopharmaceuticals, Inc. and Director at Cougar Biotechnology, Inc.

He received an undergraduate degree from The Pennsylvania State University and a doctorate from Temple University School of Medicine.


Posti e reponsabilitÓ di Lindsay Allan Rosenwald 
NomeTitolo Da
Journey Medical Corporation
(Prodotti farmaceutici)
Executive Chairman -
Checkpoint Therapeutics, Inc.
(Biotecnologia)
President, Chief Executive Officer & Director 2014
Fortress Biotech, Inc.
(Prodotti farmaceutici)
Chairman, President & Chief Executive Officer 2013
Mustang Bio, Inc.
(Biotecnologia)
Non-Executive Director 2015
Avenue Therapeutics, Inc.
(Biotecnologia)
Executive Chairman 2015
Opus Point Partners Management LLC Partner 2009
Cellvation, Inc. President & Chief Executive Officer -
Helocyte, Inc. Executive Chairman -
Cyprium Therapeutics, Inc. Executive Chairman 2017
Caelum Biosciences, Inc. Director -


Participazioni di Lindsay Allan Rosenwald 
NomeAzioni%Valorizzazione
Checkpoint Therapeutics, Inc. (CKPT)
(Biotecnologia)
326 4010,39%463 489 USD
Mustang Bio, Inc. (MBIO)
(Biotecnologia)
218 4230,21%140 883 USD
Avenue Therapeutics, Inc. (ATXI)
(Biotecnologia)
84 6630,38%23 706 USD
Journey Medical Corporation (DERM)
(Prodotti farmaceutici)
00,0000%0 USD


Lindsay Allan Rosenwald: network personale 
Le notizie pi¨ lette 
22/06ELON MUSK: Musk dice che le nuove fabbriche di automobili di Tesla 'perdono miliardi di dollari'.
MR
02/07ELON MUSK: Musk rompe il silenzio su Twitter, pubblica una foto con il Papa
MR
28/06WARREN BUFFETT: La Berkshire di Buffett acquista altre azioni di Occidental, aumentando la partecipazione a circa il 16,4%.
MR
29/06MUKESH AMBANI: Factbox-I bambini Ambani al centro del cambiamento di leadership dell'azienda indiana Reliance
MR
23/06MARK MILLER: Colonna - Vuole fare qualcosa per i suoi risparmi pensionistici in difficoltà? Non
MR
28/06RALPH HAMERS: Il responsabile della strategia di UBS lascerà la banca per dedicarsi all'imprenditoria
MR
22/06TREVOR MILTON: Il fondatore di Nikola, Trevor Milton, affronta una nuova accusa di frode
MR
01/07MARK ZUCKERBERG: obiettivo di assunzione di ingegneri per il 2022 ridotto a circa 6.000-7.000 - Domande e Risposte dei dipendenti
MR
21/06ELON MUSK: Musk dice che ci sono ancora alcune questioni irrisolte con l'offerta di Twitter.
MR
04/07LEONARDO DEL VECCHIO: Lo stretto collaboratore di Del Vecchio prende le redini dell'impero imprenditoriale
MR
Altre news


© 2022 People and Ownership :   
Lindsay Allan Rosenwald : connessioni